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Summary.-In mice, i.v. C. parvunx induces intravascular coagulation. This is a
prolonged reaction lasting up to 7 days. It results in thrombosis in hepatic vessels
with consequent hepatic necrosis, and thrombosis in pulmonary and splenic vessels.
This may be important in the assessment of the tumour-inhibitory activity of C.
parvum.
IN RODENTS, administration of killed
Corynebacterium parvum decreases the
growth of both subcutaneous and ascitic
syngeneic tumours (Woodruff and Boak,
1966; Castro, 1974a). It also inhibits
development of tumour nodules in the
lung due either to i.v. injection of tumour
cells (Milas and Mujagic, 1972; Bomford
and Olivotto, 1974) or spontaneous meta-
stases (Proctor, Rudenstam andAlexander,
1973; Sadler and Castro, 1976).
The mechanism of this anti-tumour
action is under investigation. However, as
C. parvum is a known immunopotentiating
agent (Halpern et al., 1963; Howard,
Scott and Christie, 1973), most emphasis
has been on the role played by macro-
phages and T cells (Woodruff, Dunbar
and Ghaffar, 1973; Olivotto and Bomford,
1974). In this paper we present evidence
of a non-immunological action of C.
parrum which could possibly inhibit
tumours, particularly metastases, in the
liver and lungs.
This investigation stems from the obser-
vations that mice treated with i.v. C.
parrvam show macroscopic abnormalities
of their livers (Castro, 1974b; Mosedale
and Smith, 1975) and are abnormally
sensitive to barbiturates (which are meta-
bolized in liver tissue). A histological
study was, therefore, made of the liver
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and other tissues of mice at intervals after
injection of C. parvum.
MATERIALS AND METHODS
Mice.-Age-matched, female C57BL/10
ScSn mice weighing 18-23 g were obtained
from Olac (Southern) Ltd.
C. parvrum.-A formalin-killed suspension
of C. parvum (Wellcome strain CN6134,
Batch BA 3935/A, 7 mg dry wt/ml) was
injected i.v. at a dose of 0-466 mg in 0-2 ml
normal saline. In one experiment, mice were
given 1/10, 1/100 or 1/1000 of this dose.
Control mice received an equal volume of
saline or 0-01% thiomersalate (the preserva-
tive used for the C. parvum).
Histology.-Mice were killed by cervical
dislocation in groups of 3 at 20 min, 4, 8,
16 and 24 h, and 3, 5 and 7 days after injec-
tion. Control mice, and those given reduced
doses of C. parvum, were killed on Days 1
and 3 only. The following tissues were
removed: liver, spleen, kidney, a segment of
small gut, heart, mesenteric lymph nodes and
thymus. The lungs were inflated in situ with
formol-buffered saline and removed. All tis-
sues were fixed in formol-buffered saline,
processed in paraffin wax, sectioned at 7 ,um
and stained with haematoxylin and eosin.
Platelet count.-Groups of 4 mice were
given i.v. C. parvum and blood was sampled
at 20 min, 4, 8, 16 and 24 h, and 3, 5 and 7
days after injection. Bleeding was induced
from the retro-orbital plexus using a heparin-16 I. A. LAMPERT, P. D. E. JONES, T. E. SADLER AND J. E. CASTRO
ized capillary tube (Hawksley, England),
and a 0-02-ml sample of the effusing blood
was immediately collected into a heparinized
white-backed micro-pipette. The 0-02-ml
sample was diluted in 2 ml of 1% ammonium
oxalate, in a plastic microcapped tube, and
was mechanically shaken for 3 to 5 min.
A Neubauer counting chamber was filled
with the diluted sample and left for 15 to
20 min in a moist container in order to allow
the platelets to settle. Platelets were then
counted under phase, using a x 10 objective
and the mean total count (±s.e.) estimated.
RESULTS
Within 10 to 20 min after i.v. injection
of 0-466 mg C. parvum, C57BL mice were
observed to be in respiratory distress.
They became cold to the touch and were
"hunched over". This syndrome dis-
appeared after 2 h.
Groups of 3 mice were killed at intervals
afterinjection. Some necrosis was observed
macroscopically in the liver as early as
24 h. By 7 days all of the livers were
enlarged, pale and mottled with necrotic
patches. The mean weight of the whole
body, and various tissues are shown in
the Table. There was a 5-fold increase in
spleen weight, and a doubling of liver
weight.
Histology
Twenty minutes after injection, occa-
sional thrombi surrounded by polymorphs
were seen in the sinusoids of the liver and
in the alveolar capillaries: a minority
showed polymorphs aggregated about
their periphery. At 4 h, all mice showed
numerous aggregates of polymorphs sur-
rounding fibrin thrombi in the sinusoids
of the liver, and a few similar thrombi in
the hepatic and portal veins. At 8 h,
the number of these venous thrombi
surrounded by polymorphs was increased.
In addition, thrombi were seen in the
splenic pulp sinusoids. At 16 h, infarcts,
without significant inflammatory response
in their periphery, were seen in the liver,
and the numbers ofpulmonary and splenic
thrombi were increased, with consequent
congestion of the splenic pulp. These
changes were further increased at 24 h,
the hepatic infarcts (see Figs. 1 and 2)
were concentrated at the hepatic capsule
and were also present elsewhere in the
parenchyma. When observed on the
periphery of the liver, they were roughly
triangular in shape, with the broad base
of the triangle on the capsule; frequently
there was a thrombosed vessel at the
apex. At this stage, a predominantly
macrophage response was seen at the edge
of the infarcted area.
The number and size of thrombi were
increased in the splenic pulp and in the
pulmonary vessels (see Figs. 3 and 4).
Few thrombi were seen in the medullary
vessels of the lymph nodes.
By Day 3, thrombi in the hepatic
vessels were showing organization, and
were infiltrated by phagocytic cells. A
TABLE.-Weights (Mean + s.d.) of Whole Body and Various Tissues ofGroupps of 3
Mice at Intervals after i.v. Injection of C. parvum
Time
Control
20 min
4h
8 h
16 h
24 h
3 Day
5 Day
7 Day
Whole
body
(g)
20-0±0-9
20 8±1 9
20-8±0-8
203+1 *0
19-8±0-8
19*5±0 5
19-8±0-8
21-0±0-3
20-7±1-5
* Mesenteric lymph nodes.
Liver
(mg)
914±55
971 ±52
1124±327
912 ±63
1065±93
1056±64
1189+ 131
1463 ±62
1930±31
Spleen
(mg)
85±13
85±13
102±44
89± 2
115± 5
113± 8
197±15
233 ±33
431 ±41
Kidney
(mg)
115± 5
109±13
113± 9
115± 9
110± 1
115± 7
120± 8
141± 12
142± 5
Mes*
LN
(mg)
300± 3*0
34-8+ 2-1
30 7+ 2-3
36-7± 3-5
31-3+ 3-2 35-7± 3-4
34-3+ 2-8
36-5± 6-5
29-0±10-6
Thymus
(mg)
50-0±10 4
66-2± 9.5
56-0± 9-6
54-7+18-3
58-5± 8-2
49 3± 9-8
45-5± 5-5
48-2±12 -3 35-8±11-6THROMBOSIS DUE TO I.V. C. PARVUM
Fic(1. 1. Liver, 24 h after injection of C. parvum. Thrombus in portal vein surrounded bypolymorphs. x 125.
similar infiltrate was seen at the periphery
ofthe liver infarcts, with a partial removal
of necrotic tissue. At this stage, numerous
macrophage granulomas were seen in the
hepatic parenchyma. The thrombi in the
pullmonary and splenic vessels showed
organization similar to that seen in the
liver. The splenic red pulp was increased
in size both by congestion and by an
increase in the number of mononuclear
cells.
At 5 days, the liver showed numerous
small macrophage granulomas. Large col-
lections of loosely aggregated macro-
phages marked the position of removed
hepatic parenchyma. Thrombi, surrounded
by polymorphs and not showing any form
of organization, were seen in hepatic
vessels. These were, therefore, similar to
those observed in the first 24 h. Also,
infarcts were seen in the hepatic paren-
chyma, showing absent or incomplete
karyorrhexis and no inflammatory re-
action. New thrombi, similar to those
seen in the liver, were seen in the pul-
monary and splenic vessels. The spleen
also showed a marked increase in the
number of megakaryocytes in the red
pulp. By 7 days there was extensive
replacement of the hepatic parenchyma
by granulomas, and necrotic areas of
liver. The surviving parenchymal cells
showed numerous mitoses. Occasional
megakaryocytes were seen in the liver
sinusoids.
Throughout the experiment, no abnor-
mality was seen in the kidneys, heart,
small gut or thymus. After injection of a
1/10 dilution of C. parvum, occasional
granulomas were seen in the liver, and
thrombi in the pulmonary vessels. At
higher dilutions (1/100 and 1/1000) these
became fewer.
No abnormalities were observed in the
tissues of mice which had received saline
or thiomersalate.
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FIG. 2.-Liver, 24 h after injection of C. parvum. TI
Platelet counts
There was an initial fall in platelet
count as early as 20 min after the injection
of C. parvum (Fig. 5). Subsequentlv, there
was an increase, reaching a maximum at
8 h. This was followed by a second fall
to 50% of the control value by 16 h. This
low level remained constant for 7 days,
and did not return towards normal until
21 days after injection.
DISCUSSION
At the high dose used, C. parvum
induced widespread intravascular throm-
bosis. The organ most affected was the
liver, with significant effects in the spleen
and lung. Thrombosis was mirrored by a
fall in the platelet counts. Ageing of the
thrombi was assessed by their organiza-
tion. Consequently the presence ofthrombi
in vessels surrounded by polymorphs at
hrombus in hepatic vein. Infarction of liver. x 125.
5 and 7 days suggested that these were
fresh thrombi. Further evidence that
thrombosis was continuing was the con-
tinued low platelet count, despite evidence
of megakaryocytic hyperplasia. The pres-
ence of fresh infarcts in the liver attest
to the importance ofthese thrombi.
The mechanism of this reaction is at
the moment a matter for speculation.
By analogy with the disseminated intra-
vascular coagulation (DIC) reaction caused
by endotoxin, the following mechanism
could be suggested. C. parvum, like other
particulate antigens, is known to activate
the alternate complement pathway
(McBride et al., 1975). In endotoxin shock
(Brown and Lachman, 1973) activated
C3 shows immune adherence to the
platelets of many non-primate species,
including mice (Henson, 1970). This results
in disruption of platelets, with the release
of factors which produce thrombosis.
The presence of polymorphs surroundingTHROMBOSIS DUE TO I.V. C(. PAJ?VUMT-19
FIG. 3. Spleen, 24 h after injection of C(. parvum. Thrombus in splenic sinusoid. x 125.
the thrombi suggest that this or a similar
inflammatory reaction is implicated.
Injection of C. parvum had a triphasic
effect on the platelet count. There was
an immediate decrease of )latelets, fol-
lowed by a rise and a second, prolonged,
fall. A similar alteration in platelet num-
bers has been reported after injection
of endotoxin (Brown and Lachman, 1973).
Inoculation of any particulate antigen
causes an immediate decrease of circulat-
ing )latelets as they aggregate with the
antigen and leave the circulation. The
count rises 1-2 h later as they return to
the blood. Following endotoxin there is a
later slower phase of platelet consump-
tion, which coincides with the develop-
ment of DIC. The prolonged decrease of
platelets observed after C. parvrum may
be caused by continued thrombosis or
by pooling in the enlarged spleen.
No lesions were observed in the kidney
after C. parcrum injection. This contrasts
with the disseminated coagulation seen
in a generalized Shwartzman reaction
(McKay and Merriam, 1960). The reason
for localization of thrombosis in the
endotoxin-DIC reaction is not clear, and
factors such as blood flow have been
suggested (McKay and Merriam, 1960).
In the case of C. parvum, localization is
mainly in lung, liver and spleen. With the
exception of the lung, these are organs
which have sinusoids lined by phagocytic
cells to which the bacteria probably
attach, and coagulation may then take
place on the adsorbed C. parvrum. The
lung may be involved, as it is the first
capillary bed which the bacteria meet
after injection, and clumping may occur.
It is probable that the renal glomerulus
has no affinity for C. parvum, and hence
there is no coagulation reaction.
Another unusual feature of this throm-
bosis is its long duration of at least 7 days.
Data from other work (Sadler, Cramp and
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FIG. 4.-Lung, 24 h after injection of C. parvum. Thrombus surrounded by polymorphs in small pulmonary
artery. x 325.
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Castro, 1977) have shown that 3H-
labelled C. parvum is largely cleared from
the circulation by 3 h by the Kuppfer
cells of the liver, but there is evidence of
V - I gradual release of C. parvum into the
circulation with time. It is therefore
reasonable to suggest that the thrombosis
in the later period is due to products of
C. parvum itself. By implication, these
data suggest that the active principle in
C. parvum is not easily destroyed by the
phagocytic cells of the experimental
animals used.
3days 5 7 Granulomas in the liver following C.
parvum injection have been previously :tion reported, and are presumably due to the
ts per mm3 blood localization of antigen there (McBride, ijection of saline Jones and Weir, 1974). The enlargement -. Each point of the spleen and liver in the early phases
L 4mie,ithbar of the experiment is largely due to con-
ll
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gestion. Later, in the spleen, this is
mainly due to the hyperplasia of cellular
elements, most likely mononuclear phago-
cytes (Sljivic and Warr, 1975).
There have been suggestions that coagu-
lation in animal experimental models
influences the extent and degree oftumour
metastases (Wood, 1971; Chew and Wal-
lace, 1976). Factors which reduce coagu-
lation, such as heparin, coumarin and
thrombocytopenia, have been reported
to reduce the number of metastases
(Wood, 1971; Hilgard et al., 1977; Gasic,
Gasic and Stewart, 1968; Gasic et al.,
1973) whereas protamine increases meta-
stases (Wood, 1971). However, there is
some evidence that these factors may not
affect tumour dissemination (Hagmar,
1970). Thrombocytopenia was observed
following C. parvum administration, but
it has yet to be assessed whether this has
any influence on the development of
metastases. The levels of other coagula-
tion factors (e.g. fibrinogen) have not
yet been evaluated after C. parvum
injection.
These experiments suggest that intra-
vascular coagulation follows i.v. injection
of C. parvum. Therefore, experiments
conducted to show inhibition of tumour
metastases by the blood stream have to
be assessed in the light of a possible
activation of an intravascular coagulation
state. Indeed, such a state might explain
the early death of i.v.-injected tumour
cells in the lungs of C. parvum-treated
mice (Bomford and Olivotto, 1974).
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